Inotiv is a contract research organization that provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and sells a range of animals and diets to the same industries. Co.'s segments are: Discovery and Safety Assessment, which includes Discovery Services such as Analytical Method Development and Validation, In Vivo Pharmacology, Exploratory Pharmacokinetics and Toxicology and Archiving services as well as Safety Assessment, such as Non-clinical Toxicology and Pathology Services and Stability Testing; and Research Models and Services, which includes Research Models, Diets and Bedding, and Research Model Services. We show 13 historical shares outstanding datapoints in our coverage of NOTV's shares outstanding history.
Understanding the changing numbers of NOTV shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like NOTV versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching NOTV by allowing them to research NOTV shares outstanding history
as well as any other stock in our coverage universe. |
Free NOTV Email Alerts:
Video: Shares Outstanding Importance
